Metformin Monotherapy Downregulates Diabetes-Associated Inflammatory Status and Impacts on Mortality

Metformin Monotherapy Downregulates Diabetes-Associated Inflammatory Status and Impacts on Mortality

Aging is the main risk factor for developing diabetes and other age-related diseases. One of the most common features of age-related comorbidities is the presence of low-grade chronic inflammation. This is also the case of metabolic syndrome and diabetes. At the subclinical level, a pro-inflammatory...

Full description

Bibliographic Details
Main Authors: Anteneh Mehari Tizazu, Ma Shwe Zin Nyunt, Olivier Cexus, Koolarina Suku, Esther Mok, Chin Hui Xian, Joni Chong, Crystal Tan, Wilson How, Sandra Hubert, Emilie Combet, Tamas Fulop, Tze Pin Ng, Anis Larbi
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Physiology
Subjects:
aging
diabetes
chronic inflammation
metabolic syndrome
insulin resistance
metformin
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2019.00572/full

Internet

https://www.frontiersin.org/article/10.3389/fphys.2019.00572/full

Similar Items